Actively Recruiting
Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP
Led by French Africa Pediatric Oncology Group · Updated on 2026-03-02
500
Participants Needed
3
Research Sites
476 weeks
Total Duration
On this page
Sponsors
F
French Africa Pediatric Oncology Group
Lead Sponsor
G
Gustave Roussy, Cancer Campus, Grand Paris
Collaborating Sponsor
AI-Summary
What this Trial Is About
The LALGFA2019 Recommendations redefine the standard risk criteria and propose to introduce anthracycline induction in so-called high-risk forms (LAL line T and LAL line B with leukocytosis greater than or equal to 50 G/L or in children less than 1 year of age or more than 10 years of age) as well as Endoxan and Methotrexate in high dose consolidation.
CONDITIONS
Official Title
Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 0 to 18 years
- First diagnosis of Acute Lymphoblastic Leukemia (ALL)
- No prior chemotherapy treatment
- Cytology FAB L1 or L2
You will not qualify if you...
- Diagnosis of ALL L3 (Burkitt leukemia)
- Previous treatment with chemotherapy for ALL
- Diagnosis of Trisomy 21 (Down syndrome)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
CHU de Treichville à ABIDJAN
Abidjan, Côte d’Ivoire
Actively Recruiting
2
CHU Donka 030 BP 554
Conakry, Guinea
Actively Recruiting
3
Hôpital Aristide Le Dantec, Avenue Pasteur,
Dakar, Senegal, BP 3001
Actively Recruiting
Research Team
N
Ndella Ms DIOUF, MD
CONTACT
B
BRENDA Ms MALLON, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here